Urinary exosomes and diabetic nephropathy: a proteomic approach.
Urinary exosomes (UE) are nanovesicles released by every epithelial cell facing the urinary space and they are considered a promising source of molecular markers for renal dysfunction and structural injury. Exosomal proteomics has emerged as a powerful tool for understanding the molecular composition of exosomes and has potential to accelerate biomarker discovery. We employed this strategy in the study of diabetic nephropathy (DN) and the consequent end stage renal disease, which represent the dramatic evolution of diabetes, often leading the patients to dialysis or kidney transplantation. The identification of DN biomarkers is likely to help monitoring the disease onset and progression. A label free LC-MS/MS approach was applied to investigate the alteration of the proteome of urinary exosomes isolated from the Zucker diabetic fatty rats (ZDF), as a model of type 2 DN. We collected 24 hour urine samples from 7 ZDF and from 7 control rats at different ages (6, 12 and 20 weeks old) to monitor the development of DN. Exosomes were isolated by ultracentrifugation and their purity assessed by immunoblotting for known exosomal markers. Exosomal proteins from urine samples of 20 week old rats were pooled and analyzed by nLC-ESI-UHR-QToF-MS/MS after pre-filtration and tryptic digestion, leading to the identification and label free quantification of 286 proteins. Subcellular localization and molecular functions were assigned to each protein by UniprotKB, showing that the majority of identified proteins were membrane-associated or cytoplasmic and involved in transport, signalling and cellular adhesion, typical functions of exosomal proteins. We further validated label free mass spectrometry results by immunoblotting, as exemplified by: Xaa-Pro dipeptidase, Major Urinary Protein 1 and Neprilysin, which resulted increased, decreased and not different, respectively, in exosomes isolated from diabetic urine samples compared to controls, by both techniques. In conclusion we show the potential of exosome proteomics for DN biomarker discovery.
Department of Health Sciences, Milano-Bicocca University, Via Cadore 48, 20052 Monza, Italy.
F
F
Raimondo
S
S
Corbetta
L
L
Morosi
C
C
Chinello
E
E
Gianazza
G
G
Castoldi
C
C
Di Gioia
C
C
Bombardi
A
A
Stella
C
C
Battaglia
C
C
Bianchi
F
F
Magni
M
M
Pitto
D000818:Animals; D015415:Biomarkers / Q000378:metabolism / Q000652:urine; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism* / Q000473:pathology; D003928:Diabetic Nephropathies / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D055354:Exosomes / Q000737:chemistry* / Q000235:genetics; D008297:Male; D013058:Mass Spectrometry; D011506:Proteins / Q000032:analysis*; D020543:Proteome / Q000032:analysis / Q000378:metabolism; D040901:Proteomics; D051381:Rats; D011924:Rats, Zucker; D014551:Urinary Tract / Q000378:metabolism* / Q000473:pathology
D015415:Biomarkers; D011506:Proteins; D020543:Proteome; C035737:major urinary proteins